“Bimekizumab in Patients with Moderate to Severe Plaque Psoriasis: Analysis of Mental Health and Associated Disorders” (2023) SKIN The Journal of Cutaneous Medicine, 7(6), p. s300. doi:10.25251/skin.7.supp.300.